Shenzhen Transsion Holdings Co., Ltd. (688036.SH) has filed for the issuance of H-shares with the China Securities Regulatory Commission.
Transsion Holdings (688036.SH) announced that the company is undertaking the necessary preparations to apply for the issuance of overseas listed shares (H shares) and to be listed on the main board of the Hong Kong Stock Exchange. The company recently received the Notice of Filing for Overseas Issuance and Listing of Shenzhen Transsion Holdings Co., Ltd. from the China Securities Regulatory Commission (Guohe Letter [2026] No. 1847). The company plans to issue no more than 132 million overseas listed ordinary shares and list them on the Hong Kong Stock Exchange.
Shenzhen Transsion Holdings Co., Ltd. (688036.SH) announced that the company is working on the application for the issuance of overseas listed shares (H shares) and the listing on the main board of the Hong Kong Stock Exchange. Recently, the company received the "Notice of Filing for Overseas Issuance and Listing of Shenzhen Transsion Holdings Co., Ltd." issued by the China Securities Regulatory Commission (Guo He Han [2026] No. 1847). The company plans to issue no more than 132 million overseas listed ordinary shares and list them on the Hong Kong Stock Exchange.
Related Articles
XIAOMI-W (01810) invested HKD 49.9504 million on August 6th to repurchase 1.862 million shares.
HAOHAI BIOTEC (06826) subsidiary has obtained a medical device registration certificate for its trifocal toric intraocular lens product.
HENG TAI (00197): Chan Wai Ying has been appointed as an independent non-executive director.
XIAOMI-W (01810) invested HKD 49.9504 million on August 6th to repurchase 1.862 million shares.
HAOHAI BIOTEC (06826) subsidiary has obtained a medical device registration certificate for its trifocal toric intraocular lens product.
HENG TAI (00197): Chan Wai Ying has been appointed as an independent non-executive director.
RECOMMEND
